Acquisitions18 Sept 2025, 06:11 pm
Metropolis Healthcare Ltd Completes Acquisition of Dr. RS Patil’s Ambika Pathology Laboratory
AI Summary
Metropolis Healthcare Ltd has successfully acquired ‘Dr. RS Patil’s Ambika Pathology Laboratory’ (Ambika Pathology), a sole proprietorship firm of Dr. Rajendra Sadashiv Patil, as a going concern. The acquisition was effective from September 18, 2025, as per the agreed terms under the Business Transfer Agreement (BTA). The operations of Ambika Pathology are now being carried out under the Company, effective from the same date.
Key Highlights
- Metropolis Healthcare Ltd has completed the acquisition of Dr. RS Patil’s Ambika Pathology Laboratory.
- The acquisition was effective from September 18, 2025.
- The operations of Ambika Pathology are now being carried out under the Company.
- The acquisition was carried out as per the agreed terms under the Business Transfer Agreement (BTA).
- The other terms and conditions, including deferred consideration, will be carried out in accordance with the BTA.